or Try an Advanced Search...

    Inflammatory Bowel Disease Stocks List

    Symbol Grade Name % Change
    EXAS F Exact Sciences Corporation 0.44
    GLPG F Galapagos NV 1.31
    RDHL F Redhill Biopharma Ltd. -0.04
    SYBX F Synlogic, Inc. -0.64
    BLRX F BioLineRx Ltd. -9.05
    ABVX F ABIVAX Société Anonyme 4.95
    VTYX D Ventyx Biosciences, Inc. -0.62
    SYRE D Spyre Therapeutics, Inc. 2.64
    MORF D Morphic Holding, Inc. -1.46
    SRZN D Surrozen, Inc. 1.91
    View As Page of Charts
    Related Industries: Biotechnology Conglomerates Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Autoimmune Disease Medicine Clinical Development Colitis Rheumatoid Arthritis Ulcerative Colitis Diarrhea Abdominal Pain Biopharmaceutical Biotechnology Cancer Clinical Medicine Drugs Gastroenterology Treatment Of Inflammatory Bowel Disease Ulcer Acid Acute Myeloid Leukemia Acute Respiratory Distress Syndrome Anthrax

    Related ETFs - A few ETFs which own one or more of the above listed Inflammatory Bowel Disease stocks.

    Symbol Grade Name Weight
    EKG C First Trust Nasdaq Lux Digital Health Solutions ETF 3.18
    CANC D Tema Oncology ETF 2.85
    ARKG D ARK Genomic Revolution Multi-Sector ETF 2.74
    LABD F Direxion Daily S&P Biotech Bear 3X Shares 2.69
    BTEC C Principal Healthcare Innovators Index ETF 2.59
    View all Inflammatory Bowel Disease ETFs...
    Compare ETFs
    Compare ARKG to BTEC Compare CANC to BTEC Compare EKG to CANC

        Inflammatory Bowel Disease Stocks Recent News

        Date Stock Title
        May 31 MORF Morphic to Participate in Jefferies Global Healthcare Conference
        May 30 GLPG Adaptimmune, Galapagos to collaborate on uza-cel T-cell therapy
        May 30 GLPG Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications
        May 30 GLPG Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications
        May 30 BLRX BioLineRx stock jumps 14% on St. Jude clinical trial for mitoxafortide
        May 30 EXAS How Is The Market Feeling About Exact Sciences?
        May 30 BLRX BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)
        May 29 EXAS Exact Sciences (EXAS) Witnesses Rising Expenses, Competition
        May 29 SYRE Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference
        May 28 BLRX BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript
        May 28 EXAS Exact Sciences (EXAS) to Showcase Favorable Research Outcome
        May 28 BLRX biolinerx GAAP EPS of $0.00 beats by $0.29, revenue of $6.86M beats by $6.52M
        May 28 BLRX BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
        May 28 EXAS Exact Sciences to Participate in June Investor Conferences
        May 27 EXAS Hedge Funds are Bullish on This Cancer Stock
        Related Industries: Biotechnology Conglomerates Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Autoimmune Disease Medicine Clinical Development Colitis Rheumatoid Arthritis Ulcerative Colitis Diarrhea Abdominal Pain Biopharmaceutical Biotechnology Cancer Clinical Medicine Drugs Gastroenterology Treatment Of Inflammatory Bowel Disease Ulcer Acid Acute Myeloid Leukemia Acute Respiratory Distress Syndrome Anthrax
        Inflammatory Bowel Disease

        Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's disease and ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.

        More about Inflammatory Bowel Disease
        Browse All Tags